Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Femoral nerve block with bupivacaine ± dexamethasone in hip fracture
2014-001702-18Phase 4Terminated
- Sponsor
- Thomas Fichtner Bendtsen
- Start
- Jul 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hip fracture, Neck Of Femur Fracture and acute pain comparing Bupivacaine alone femoral nerve block with Bupivacaine + dexamethasone femoral nerve block (2 arms). Primary endpoint: Primary analgesia duration endpoint. Started Jul 2014; status: terminated.
02
Drugs
bupivacainedexamethasone
03
Conditions
hip fractureNeck Of Femur Fractureacute pain
Beyond the preview
Go deeper on 2014-001702-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001702-18.